Answers are grounded in this paper and cite their sources.
Core-binding factor (CBF) acute myeloid leukemia (AML), defined by the presence of the RUNX1::RUNX1T1 or CBFB::MYH11 fusion genes, constitutes approximately 15% of all cases of newly diagnosed AML ...
No takes yet. Share an insight, caveat, or question.
Azevedo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: